The bidding window for Snehaa Organics SME IPO was open from August 29, 2025, to September 2, 2025. The basis of allotment will be finalised today, September 3, 2025. Here’s how you can check the IPO allotment status.
Snehaa Organics IPO is a book-building issue of ₹32.68 crores, consisting entirely of a fresh issue of 0.27 crore equity shares. The price band is set at ₹115 to ₹122 per share. The tentative listing on NSE Emerge is scheduled for September 5, 2025.
Fast Track Finsec Pvt. Ltd. is the book-running lead manager, and Skyline Financial Services is the registrar for the issue.
The net proceeds from the fresh issue will be used towards the following purposes:
(September 2, 2025, end of the day)
Category |
Subscription (times) |
Qualified Institutional Investors (QIBs) |
42.19 |
Non-Institutional Investors (NIIs) |
16.23 |
Individual Investors (IND category bidding for 2 Lots) |
37.75 |
Total |
27.75 |
As of 3 September 2025, Snehaa Organics' IPO’s GMP stood at ₹4. The estimated listing price is ₹126, i.e., a 3.28% gain per share over the upper price band.
Source: InvestorGain Report dated 3 September 2025 Disclaimer: The GMP (Grey Market Premium) price is an unauthenticated market related news and has no discernible basis. The same quoted above is as per news appeared in the media report and is for information purposes only. The investor shall do their own study/research before using the same for taking any decision to invest. We neither engage in, trade, or deal in the grey market nor we recommend or endorse trading in the grey market. |
Snehaa Organics is engaged in the business of solvent recovery and recycling. They help industries that use solvents in their processes by collecting used solvents and cleaning them so they can be used again.
In addition to the core recovery operations, the company is also actively engaged in solvent trading. They procure solvents from reliable sources, carry out in-house quality checks, and distribute them through their established network in the open market.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here